Home
Roland Jonsson's picture

Roland Jonsson

Professor, Past Broegelmann Chair in Immunology
  • E-mailRoland.Jonsson@uib.no
  • Phone+47 55 97 46 49+47 911 48 189
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2010. The fibroblast integrin alpha 11 beta 1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. Journal of Biological Chemistry. 10434-10445.
  • 2010. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1235-1238.
  • 2009. The minor salivary gland proteome in Sjögren´s syndrome. Oral Diseases. 342-353.
  • 2009. Levels of dendritic cell populations and regulatory T cells vary significantly between two commonly used mouse strains. Scandinavian Journal of Immunology. 541-546.
  • 2009. Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome. Rheumatology. 1102-1106.
  • 2009. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes and Immunity. 68-76.
  • 2008. Sjögrens syndrom. Norsk Epidemiologi. 67-72.
  • 2008. New Concepts in the Pathogenesis of Sjogren's Syndrome. Rheumatic Disease Clinics of North America. 833-+.
  • 2008. Inhibition of experimental Sjögren's syndrome through immunization with Hsp60 and its peptide amino acids 437-460. Arthritis and Rheumatism. 2318-2328.
  • 2008. Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Annals of the Rheumatic Diseases. 949-954.
  • 2008. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Research & Therapy. 14 pages.
  • 2007. The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. Arthritis Research & Therapy. 1-15.
  • 2007. Sjögren's syndrome - A plethora of clinical and immunological phenotypes with a complex genetic background. Annals of the New York Academy of Sciences. 433-447.
  • 2007. Serological Implications of Germinal Center-like structures in Primary Sjögren’s Syndrome. Journal of Rheumatology. 2044-2049.
  • 2007. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. S57.e1-S57.e15.
  • 2007. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scandinavian Journal of Immunology. 92-98.
  • 2006. The thymus is a source of B-cell-survival factors–APRIL and BAFF–in myasthenia gravis. Journal of Neuroimmunology. 161-166.
  • 2006. Polymyalgia rheumatica in primary Sjogren's syndrome. Rheumatology International. 401-403.
  • 2006. A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology. 1466-1476.
  • 1999. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine. 82-87.
  • 1999. Rheumatoid factors in primary Sjögren's syndrome (PSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clinical and Experimental Immunology. 388-394.
  • 1999. Changes in T-Lymphocyte Subsets in Lungs and Spleens of Mice with Slowly Progressive Primary Mycobacterium tuberculosis Infection: Involvement of Unconventional T-Cell Subsets. Scandinavian Journal of Immunology. 137-144.
  • 1998. Transfer of human serum IgG to NOD.Ig<SUP>_mnull</SUP> mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues Sjögren´s syndrome. Proceedings of the National Academy of Sciences of the United States of America. 7538-7543.
  • 1998. The role of apoptosis in Sjögren´s syndrome. Annales de médecine interne. 25-29.
  • 1998. Immunopahtology of mucous membranes and exocrine glands - Conference summary. Arthritis and Rheumatism. 572-576.
  • 1998. Expression of the mucosal lymphocyte integrin _a<SUP>E_b</SUP><SUB>7</SUB> and its ligand E-cadherin in salivary glands of patients with Sjögren´s syndrome. Scandinavian Journal of Rheumatology. 215-218.
  • 1998. Expression of the mucosal lymphocyte integrin _a<SUP>E_b</SUP><SUB>7</SUB> and its ligand E-cadherin in salivary glands of patients with Sjögren´s syndrome. Scandinavian Journal of Rheumatology. 215-218.
  • 1998. Expression of the Mucosal Lymphocyte Integrin alfaEbeta7 and its Ligand E-cadherin in Salivary Glands of Patients with Sjogren's Syndrome. Scandinavian Journal of Rheumatology. 215-218.
  • 1998. Detection of anti-Ro/SSA and anti-La/SSB autoantibody producing cells in salivary glands from patients with Sjögren´s syndrome. Arthritis and Rheumatism. 2238-2248.
  • 1998. Detection of anti-Ro/SSA and anti-La/SSB autoantibody producing cells in salivary glands from patients with Sjögren´s syndrome. Arthritis and Rheumatism. 2238-2248.
  • 1998. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R. Scandinavian Journal of Immunology. 179-188.
  • 1998. A novel NOD-derived murine model for primary Sjögren´s syndrome. Arthritis and Rheumatism. 150-156.
  • 1997. What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci. Tidsskrift for Den norske legeforening. 4109-4113.
  • 1997. Immunopathology of the gut and related extraintestinal disorders - Meeting report. The Immunologist. 210-213.
  • 1997. Immunocompetent cells in normal rat periodontal ligament and their recruitment incident to experimental orthodontic tooth movement. European Journal of Oral Sciences. 36-44.
  • 1997. Immune Responses in Mice After Gastric and Subcutaneous Immunization with BCG. Scandinavian Journal of Immunology. 274-280.
  • 1997. Immune Responses in Mice After Gastric and Subcutaneous Immunization with BCG. Scandinavian Journal of Immunology. 274-280.
  • 1997. Differential immunological abberations in patients with primary and secondary Sjögren's syndrome. Scandinavian Journal of Immunology. 698-705.
Academic lecture
  • 2019. Assessment of major salivary gland ultrasonography in Sjögren’s syndrome.
  • 2004. Sjögren's syndrome: Clinical presentation, biology and therapeutic approach.
  • 2004. Germinal Centres in Sjögren's syndrome.
  • 2004. Germinal Centers in Primary Sjögren�s Syndrome Indicate a Certain Clinical Immunological Phenotype.
  • 2003. The Association of B-cell Activating Factor (BAFF) and Ectopic Germinal Centre Formation in Sjögren’s Syndrome.
  • 2003. The Association of B-cell Activating Factor (BAFF) and Ectopic Germinal Center Formation in Sjögren’s Syndrome.
  • 2003. Sjögren's syndrome and experimental disease model system.
  • 2003. Genetic Control of Human and Experimental Sjögren's syndrome.
  • 2003. Apoptosis, loss of B cell tolerance and lymphoid neogenesis in Sjögren's syndrome.
  • 2003. Apoptosis and loss of B cell tolerance in Sjögren's syndrome.
  • 2002. What's new in Sjögren's syndrome: genetics?
  • 2002. The genetic control of human and experimental Sjögren's syndrome.
  • 2002. Subcellular redistribution and surface exposure of the Ro52, Ro60 and LA48 autoantigens during apoptosis in human ductual epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
  • 2002. Sjögren's syndrome: current issues in diagnosis, autoantibodies and pathogenesis.
  • 2002. Role of autoantibodies in Sjögren's syndrome.
  • 2002. Patogenese ved systemisk lupus erythematosus og Sjögren's syndrome.
  • 2002. Influenzaantigenspecific cells in human nasal mucosa.
  • 2002. Influenza-specific antibody producing cells in human nasal mucosa.
  • 2002. Influenza-specific antibody producing cells in human nasal mucosa.
  • 2002. Influenza specific antibodysecreting cells in nasal mucosa, prior to and after vaccination.
  • 2002. Influenza specific antibody secreting cells in nasal mucosa.
  • 2002. Immunology of the ocular surface and tearfilm: comparison of lacrimal and salivary glands.
  • 2002. Immunology of salivary glands diseases: the role of autoantibodies in Sjögren's syndrome.
  • 2002. Current understanding of Sjögren's syndrome.
  • 2001. The basal level of influenza specific antibody secreting cells in healthy subjects.
  • 2001. Influenza specific antibody secreting cells (I-ASC)in human nasal mucosa. Relation to tonsil, blood and parenteral vaccination.
  • 2001. Influensaantigenspecifika, antikroppsproducerande lymfocyter i human nasal slemhinne.
  • 2000. Monozygotic twins with primary Sjögren's syndrome.
  • 2000. HLA markers and clinical characteristics in caucasians with primary Sjögren's syndrome.
  • 2000. Fas-induced apoptosis is a rare event in Sjøgren's syndrome.
  • 2000. Antibodies against influenza virus secreted by tonsillar B cells following vaccination og young adults.
  • 1999. The 100-year anniversary of Henrik Sjögren.
  • 1999. Serological screening for hepatitis B, C and human herpes virus 6 in norwegian primary Sjögren's syndrome patients.
  • 1999. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
  • 1999. Fine mapping of a locus in chromosome 2q involved in susceptibility for systemic lupus erythematosus.
  • 1999. Candidate gene analysis in patients with primary Sjögren´s syndrome: Screening for mutations in the Ro-52 gene.
  • 1999. Apoptosis and expression of apoptosis associated proteins in oral squamous cell carcinoma.
  • 1998. Transfer of human serum IgG to nonobese diabetic Ig<SUP>_mnull</SUP> mice reveals a role for autoanitbodies in the loss of secretory function of exocrine tissues in Sjögren´s syndrome.
  • 1998. Transfer of human serum IgG to NOD. Ig<SUP>_mnull</SUP> mice reveals a role for autoantibodies in Sjögren´s syndrome.
  • 1998. The influence of different genes on the development of murine sialadenitis.
  • 1998. The influence of age on clinical features and laboratory parameters in primary Sjögren´s syndrome.
  • 1998. The influence of age on clinical features and laboratory findings in primary Sjögren´s syndrome.
  • 1998. Supression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
  • 1998. Structural comparison of rheumatoid factors (RF) from patients with primary Sjögren´s syndrome, rheumatoid arthritis (RA), and healthy immunized donors (HID).
  • 1998. Sensitivity and reliability of diagnostic tests for primary Sjögren´s syndrome.
  • 1998. Screening for mutations in the <I>La</I>-gene of patients with primary Sjögren´s syndrome by fluorescent labeling REF-SSCP technique.
  • 1998. Rheumatoid factor (RF) in primary Sjögren´s syndrome.
  • 1998. Reliability and sensitivity of diagnostic tests in Sjögren´s syndrome.
  • 1998. Molecular biology of tuberculosis.
  • 1998. Molecular biology of tubercolosis.
  • 1998. Influence of stress on immune cell recruitment in rat gingival tissues.
  • 1998. Increased number of IL-6 and IL-10 secreting cells in peripheral blood from patients with primary Sjögren´s syndrom.
  • 1998. Increased frequency of IL-6 and IL-10 secreting cells in peripheral blood from primary Sjögren´s syndrome patients.
  • 1998. Identification of susceptibility genes in Sjögren´s syndrome: The candidate gene approach.
  • 1998. Identification of susceptibility genes in Sjögren´s syndrome.
  • 1998. Frequency of IFN-_g, IL-6 and IL-10 secreting cells in peripheral blood from primary Sjögren´s syndrome patients.
  • 1998. Distribution of HLA class II alleles in a Norwegian Population of Sjögren´s syndrome patients.
  • 1998. Detection of polymorphisms in the genes encoding Fas and Fas ligand in patients with primary Sjögren´s syndrome.
  • 1998. Critical antigens of <I>Fusobacterium nucleatum</I> which may play a role in the development of periodontitis.
  • 1998. Creation of primary murine models for Sjögren´s syndrome by replacement of NOD MHC.
  • 1998. Cooperative network on the genetics of systemic lupus erythematosus.
  • 1998. Compartmentalized immune responses in the spleens and lungs of chronically Mycobacterium tuberculosis infected mice.
  • 1998. Compartmentalized immune responses in the spleens and lungs of chronically Mycobacterium tuberculosis infected mice.
  • 1998. Compartmentalized immune responses in the spleens and lungs of chronically <I>mycobacterium tuberculosis</I> infected mice.
  • 1998. A novel mechanism of immune evasion by Mycobacterium tuberculosis.
  • 1998. A novel mechanism of immune evasion by <I>Mycobacterium tuberculosis</I>.
  • 1997. The prevalence of thyroid antibodies in primary Sj@øgren's syndrome (PSS).
  • 1997. Screening for mutations in the <i>fas</i> gene in patientes with primary Sj@øgren's syndrome.
  • 1997. Rheumatoid factor (RF) clones from patients with primary Sjøgren's syndrome (SS).
  • 1997. Rheumatoid factor (RF) clones from patients with primary Sjøgren's syndrome (SS).
  • 1997. Levels of spontaneous anti-Ro/SS-A secreting cells in peripheral blood and salivary glands of Sj@øgren's syndrome patients.
  • 1997. Genetics sharing og susceptibility to arthritis, sialadenitis, diabetes and encephalmoyelitis.
  • 1997. Expression of the "mucosal" lymphocyte integrin _a<sup>E</sup>_b<sub>7 </sub> and its ligand E-cadherin in salivary glands of Sj@øgren's syndrome patients.
  • 1997. Elispot assay for teh quantitation of B-cells producing antibodies against HIV-1 P24 in pharyngeal tonsils.
  • 1997. Different immunological abberations in patients with primary and secondary Sj@øgren's syndrome.
  • 1997. Collaborative network on the genetics of systemic lupus erythematosus and Sjøgren's syndrome: towards the determination of susceptibility loci through a genome-wide microsattelite scanning.
  • 1997. Collaborative network on the genetics of systemic lupus erythematosus and Sjøgren's syndrome: towards the determination of susceptibility loci through a genome-wide microsattelite scanning.
  • 1997. Characterisation of rheumatoid factor (RF) autoantibody clones in primary Sjøgren's syndrome.
  • 1997. Characterisation of Rheumatoid Factor (RF) autoantibody clones in primary Sjøgren's syndrome.
  • 1997. Calprotectin in oral fluids with special reference to adult periodontitis.
  • 1997. Apoptosis in oral lichen planus.
  • 1997. Apoptosis and expression of Fas and FasL in oral squamous cell carcinoma and normal oral mucosa.
  • 1997. Anti-Ro/SS-A and anti-La/SS-B antibodies in serum and saliva of patients with Sj@øgren's syndrome.
  • 1997. Anti-Ro and anti-La autoantibody producing cells in salivary glands from patients with Sj@øgren's syndrome.
  • 1997. Anti-Ro and anti-La autoantibody producing cells in salivary glands from patients with Sj@øgren's syndrome.
  • 1996. Mucosal antibodies to group B streptococci in the female genital tract. Abstract 67.
  • 1996. Local antibodies to group B streptococci in the cervix of pregnant women. Abstract R 11.
  • 1993. Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • 1993. Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • 1993. Antibodies against influenza virus secreted by tonsillar B cells following vaccination of young adults.
Academic anthology/Conference proceedings
  • 2007. Immunologisk forskning i Bergen, Broegelmanns Forskningslaboratorim 1957-2007. Broegelmanns Legat.
Abstract
  • 2018. Ultrasonography of major salivary glands in juvenile Sjögren’s syndrome: an international multicentre study. Clinical and Experimental Rheumatology. S-248.
  • 2018. Salivary gland ultrasound in patients with Sjögren’s syndrome – A comparison between bed-side, video and still-image scoring. Clinical and Experimental Rheumatology. S-324.
  • 2018. Distinct and persistent cytokine profiles associated with histopathological features in primary Sjögren’s syndrome. Clinical and Experimental Rheumatology. S-295.
  • 2017. Primært Sjogrens syndrom karakteriseres av mikrobiell dysbiose (ubalanse) selv ved normal spyttsekresjon. Den norske tannlegeforenings tidende. 262-263.
  • 2013. Type 1 Regulatory T cells and Regulatory B Cells Induced by Dexamethasone and 1,25-Dihydroxyvitamin D3 Treated Monocyte-Derived Dendritic Cells. Scandinavian Journal of Immunology. 299-300.
  • 2013. The NKp30/B7H6 Axis Contributes To Pathogenesis In Primary Sjogren's Syndrome. Arthritis and Rheumatism. S1185-S1185.
  • 2013. The Importance Of Germinal Center-Like Structures In Primary Sjogren's Syndrome Salivary Glands Beyond Lymphoma Risk. Arthritis and Rheumatism. S1234-S1234.
  • 2013. Modulation of experimental Sjögren's Syndrome and diabetes via mucosal vaccination with fusion proteins derived from cholera-toxin and heat shock protein 60 kDa. Scandinavian Journal of Immunology. 321-321.
  • 2013. Is Ultrasonography Of Salivary Gland a Validate Tool In Sjogren Syndrome? Study 1: Interobserver Reliability Between International Group Of Experts. Arthritis and Rheumatism. S223-S223.
  • 2013. Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding. Arthritis and Rheumatism. S1184-S1185.
  • 2013. Carbamylation of immunoglobulin abrogates the classical pathway of complement activation. Immunology. 76-76.
  • 2012. Ultrasonography of Major Salivary Glands in Primary Sjogren's syndrome. Arthritis and Rheumatism. S925-S925.
  • 2012. No association of primary Sjögren's Syndrome with Fc gamma? Receptor gene variants. Scandinavian Journal of Immunology. 198-198.
  • 2012. Modulation of experimental Sjögren's syndrome and diabetes via mucosal vaccination with fusion proteins derived from cholera-toxin and heat shock protein 60 kDa. Immunology. 766-766.
  • 2012. Hyperreactive B cells upon endosomal TLR triggering underlying primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 199-200.
  • 2012. Genetic associations to germinal centre formation in primary Sjögren's syndrome. Immunology. 580-580.
  • 2012. Genetic associations to germinal centre formation in primary Sjögren's Syndrome. Arthritis and Rheumatism. S227-S227.
  • 2012. Genetic associations to germinal centre formation in primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 203-203.
  • 2012. Genetic Variation in the NCR3 Locus Is Associated with Anti-SSA/SSB Positive Primary Sjogren's Syndrome in Scandinavian Samples. Arthritis and Rheumatism. S228-S228.
  • 2012. Expression of Toll-like receptors 7 and 9 in B cell populations of patients with Sjogren's syndrome. Immunology. 331-331.
  • 2012. Comparison of different protocols for the generation of monocytes-derived tolerogenic dendritic cells for immunotherapy. Immunology. 679-679.
  • 2012. A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome. Arthritis and Rheumatism. S1133-S1133.
  • 2011. Vaccination of patients with primary Sjögren's syndrome reveals hyperreactive B cell compartment with a skewed maturation pattern. Annals of the Rheumatic Diseases. A67-A67.
  • 2011. Vaccination of Patients with Primary Sjogren's Syndrome Reveals Hyperreactive B Cell Compartment. Scandinavian Journal of Immunology. 369-369.
  • 2011. Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome. Arthritis and Rheumatism. S251-S251.
  • 2011. Maturation of Dendritic Cells with the Bacterial Compound OK432 Induces High Secretion of IL-12p70 in a TLR3 Dependent Manner. Scandinavian Journal of Immunology. 387-388.
  • 2011. Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC. Arthritis and Rheumatism. S303-S304.
  • 2011. Generation of Tolerogenic Monocyte-Derived Dendritic Cells. Scandinavian Journal of Immunology. 378-379.
  • 2011. Can Levels of Blood Plasmacytoid Dendritic Cells be used as a Prognostic Factor for Development of Squamous Cell Carcinomas in Organ Transplant Recipients? Scandinavian Journal of Immunology. 394-394.
  • 2011. A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with MHC, IRF5, and BLK. Arthritis and Rheumatism. S184-S184.
  • 2010. Prednisolon Reduce Cytokine but Increase Autoantibody Levels in Patients with Primary Sjogren's Syndrome. Scandinavian Journal of Immunology. 491-491.
  • 2010. Patients with Primary Sjogren's Syndrome have Significantly Reduced Amounts of Plasmacytoid and Type 2 Myeloid Dendritic Cells in Peripheral Blood. Scandinavian Journal of Immunology. 479-479.
  • 2010. Maturation of Monocyte Derived Dendritic Cells With OK432 Leads to Altered Expression of Surface Markers. Scandinavian Journal of Immunology. 504-504.
  • 2010. Gene Variants in Fam167A-Blk and Tnfsf4 are associated with Primary Sjogren's Syndrome. Scandinavian Journal of Rheumatology. 32-32.
  • 2010. Fc gamma receptor IIA, IIIA and IIIB single nucleotide polymorphisms and Fc gamma receptor IIIB copy number variation: No association with primary Sjögren's syndrome. Scandinavian Journal of Rheumatology. 36-36.
  • 2010. Association between Lymphotoxin Alpha Genetic Variants and Primary Sjögren`s Syndrome in Scandinavian Samples. Arthritis and Rheumatism. 788-789.
  • 2008. Use of bladder capacity and uroflowmetry to elucidate lower urinary tract symptoms (LUTS) in primary Sjögren’s Syndrome (PSS). Annals of the Rheumatic Diseases. 617-617.
  • 2008. Maturation of monocyte derived dendritic cells with OK432 leads to altered expression of surface markers. Scandinavian Journal of Immunology. 217-217.
  • 2008. Inhibition of experimental Sjögren's syndrome through immunization with heat-shock protein 60kDa and its peptide aa437-460. Arthritis and Rheumatism. S795-S795.
  • 2008. Histopathology in Seropositive Focus Score Negative Primary Sjögren’s Syndrome. Annals of the Rheumatic Diseases. 470-470.
  • 2008. Heterogeneity of plasma cell subsets found in the bone marrow of autoimmune NOD.B10.H2b mice. Scandinavian Journal of Immunology. 206-206.
  • 2008. Autoantigens Ro52 and Ro60 but not La48 are associated to membrane structures in HeLa cells. Scandinavian Journal of Immunology. 202-202.
  • 2008. Association of Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with BLK. Clinical Immunology. S41-S41.
  • 2008. Association of BLK with Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) initially identified by whole genome DNA pooling. Arthritis and Rheumatism. S791-S791.
  • 2008. Age-related distribution of cDC and pDC in salivary glands of NOD mice. Scandinavian Journal of Immunology. 206-207.
  • 2008. Additive effects of the major risk Alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Arthritis and Rheumatism. S430-S430.
  • 2007. Regulation of alpha11beta1 integrin levels in vitro; Identification of mechanical strain as a positive regulator of alpha11 integrin expression. Inflammation Research. S391.
  • 2007. Identification of cell surface autoantigens in Sjögren's syndrome. Inflammation Research. S457-S457.
  • 2007. Current understanding of Sjögren's syndrome. European Journal of Clinical Investigation. 32-32.
  • 2006. News and views about Sjogren's syndrome. Scandinavian Journal of Rheumatology. 28-29.
  • 2006. Germinal centers in primary Sjogren's syndrome indicate a certain clinical immunological phenotype. Scandinavian Journal of Rheumatology. 21-22.
  • 2006. Exocrine function in Sjogren's syndrome: Natural course and prognostic factors. Annals of the Rheumatic Diseases.
  • 2004. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjogren&apos;s syndrome with a special 2 emphasis on BAFF. Arthritis and Rheumatism. S578-S578.
  • 2004. Gene expression profiling of minor salivary glands in primary Sjögren's syndrome clearly groups patients and healthy control indiviluals. Arthritis and Rheumatism. S577-S577.
  • 2004. Apoptosis, loss of B-cell tolerance and lymphoid neogenesis in Sjogren&apos;s syndrome. Arthritis Research & Therapy. S50-S50.
Academic literature review
  • 2019. Primary Sjögren's syndrome and the eye. 119-132.
  • 2016. Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. 133-142.
  • 2014. Comparison of the American-European Consensus Group Sjögren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. 31-38.
  • 2012. Predictors for the development of non-Hodgkin lymphoma in primary Sjögren’s syndrome. 511.
  • 2012. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. 276-280.
  • 2011. The complexity of Sjögren's syndrome: Novel aspects on pathogenesis. 1-9.
  • 2011. Sjögren's syndrome: studying the disease in mice. 16 pages.
  • 2010. Sjögren's Syndrome.
  • 2009. Aspects of B-cell non-Hodgkin's lymphoma development: A transition from immune-reactivity to malignancy. 387-400.
  • 2008. The complex role of vitamin D in autoimmune diseases. 261-269.
  • 2008. Anti-CD20 treatment in Primary Sjogren's Syndrome. 554-564.
  • 2007. Role of B cells in Sjögren's syndrome - from benign lymphoproliferation to overt malignancy. 2159-2170.
  • 2007. Animal models of Sjögren's syndrome. 215-224.
  • 2006. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: A potential breakthrough diagnostic and individualized therapy-design tool. 236-242.
  • 2005. Sjögren's syndrome. 101-113.
  • 2005. Gene therapeutics in Sjögren's syndrome. 763-772.

More information in national current research information system (CRIStin)

Research groups